Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-009153
Date:2021-02-26
Issuer: FORMA THERAPEUTICS HOLDINGS, INC. (FMTX)
Original Submission Date:

Reporting Person:

SHEGOG TODD
C/O FORMA THERAPEUTICS HOLDINGS, INC.
500 ARSENAL STREET, SUITE 100 WATERTOWN, MA 02472

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-02-26 A 16,500 a $0.00 16,500 direct
COMMON STOCK 2021-02-26 A 12,000 a $0.00 28,500 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 38.61 2021-02-26 deemed execution date A 50,250 (a) 2031-02-25 common stock 50,250 $38.61 0 direct
Footnotes
IDfootnote
f1 these shares represented restricted stock units and will be settled into common stock upon vesting. each restricted stock unit would be converted into one share of fmtx common stock.
f2 25% of the shares subject to the stock option shall vest on february 22, 2022, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.

Elevate your investments